Sodium valproate inquiry delay
Deputy Conway-Walsh criticises the long delay in starting the inquiry into sodium valproate and notes the lack of redress compared with other countries. The Health Minister says she is happy to meet the group, but the Deputy insists the inquiry must finally begin.
Today marks a full year since the announcement of the appointment of Ms Bríd O'Flaherty as chairperson of the inquiry into the historical licensing and use of sodium valproate in women of child-bearing age. It is almost six years since the then Minister for Health announced the inquiry in November 2020. Why is the inquiry yet to commence?
Thousands of women in Ireland were prescribed Epilim despite emerging evidence of its harmful effects during pregnancy. In France, a redress scheme has been established. In Britain, an inquiry has been held and the government there has committed to a redress scheme. Why is the Government here so reluctant to do the right thing by women in Ireland? When will the Minister for Health reply to the Organisation for Anti-Convulsant Syndrome, OACS, which has requested a meeting? This inquiry needs to get up and running. I understand the need for robust regulations and terms of reference but it is wholly unacceptable that this is taking so long.
Comment on this
I am happy to meet with the group. This is something that I have worked with Epilepsy Ireland on in the past. I am familiar with the issues. I will very happily meet the group.
Comment on this
Six years on; it has to get started.